chitosan has been researched along with Toxoplasmosis, Animal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Li, H; Liang, X; Shen, J; Sun, W; Wang, Y; Yu, L; Zhang, J; Zhuang, B | 1 |
| Amiri, H; Khorshidvand, Z; Maghsood, AH; Shirian, S; Zamani, A | 1 |
| Cong, H; Guo, J; He, S; Li, Y; Sun, X; Wang, T; Yin, H; Zhou, C; Zhou, H | 1 |
| Allam, AF; Farag, HF; Fawzy Hussein Mogahed, NM; Hagras, NA; Osman, MM; Shalaby, TI; Shehab, AY; Tolba, MM | 1 |
4 other study(ies) available for chitosan and Toxoplasmosis, Animal
| Article | Year |
|---|---|
Immunological evaluation of a recombinant vaccine delivered with an analogous hyaluronic acid chitosan nanoparticle-hydrogel against Toxoplasma gondii in mice.
Topics: Animals; Antibodies, Protozoan; Chitosan; Cytokines; Hyaluronic Acid; Hydrogels; Mice; Mice, Inbred BALB C; Nanoparticles; Protozoan Proteins; Toxoplasma; Toxoplasmosis, Animal; Vaccines, DNA; Vaccines, Synthetic | 2023 |
Immunomodulatory chitosan nanoparticles for Toxoplasma gondii infection: Novel application of chitosan in complex propranolol-hydrochloride as an adjuvant in vaccine delivery.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Animals; Antigens, Protozoan; Chitosan; Cytokines; Immunity, Cellular; Immunoglobulin G; Mice; Mice, Inbred BALB C; Propranolol; Protozoan Proteins; Protozoan Vaccines; Toxoplasma; Toxoplasmosis, Animal; Vaccines, DNA | 2023 |
Chitosan Microsphere Used as an Effective System to Deliver a Linked Antigenic Peptides Vaccine Protect Mice Against Acute and Chronic
Topics: Animals; Antibodies, Protozoan; Chitosan; Disease Models, Animal; Epitopes, B-Lymphocyte; Epitopes, T-Lymphocyte; Female; Humans; Immunity, Cellular; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microspheres; Protozoan Proteins; Protozoan Vaccines; Toxoplasma; Toxoplasmosis, Animal | 2018 |
Successful treatment of acute experimental toxoplasmosis by spiramycin-loaded chitosan nanoparticles.
Topics: Acute Disease; Animals; Ascitic Fluid; Biocompatible Materials; Blood-Brain Barrier; Brain; Chitosan; Coccidiostats; Drug Combinations; Drug Delivery Systems; Kaplan-Meier Estimate; Liver; Male; Metronidazole; Mice; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Pilot Projects; Spiramycin; Spleen; Survival Rate; Tablets; Toxoplasma; Toxoplasmosis, Animal | 2019 |